CLOV vs BB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 17, 2026

CLOV

39.0
AI Score
VS
BB Wins

BB

61.6
AI Score

Investment Advisor Scores

CLOV

39score
Recommendation
SELL

BB

62score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CLOV BB Winner
Forward P/E 37.7358 43.4783 CLOV
PEG Ratio 0 1.4722 Tie
Revenue Growth 55.6% 25.6% CLOV
Earnings Growth 0.0% 216.3% BB
Tradestie Score 39.0/100 61.6/100 BB
Profit Margin -0.7% 10.3% BB
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD BB

Relative Price Performance (Last 90 Days)

CLOV 1M: +6.8% · 3M: -7.7% BB 1M: -12.5% · 3M: -16.7%

Current Technical Phase

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.1 · Price: $4.56

BB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 41

RSI (14): 41.0 · Price: $7.64

Fundamentals Snapshot

Metric CLOV BB
Market Cap
Forward P/E 28.8 46.5
Trailing P/E 78.3
Revenue (TTM)
Revenue Growth 0.6% 0.3%
Gross Margin 0.2% 0.8%
Operating Margin 0.0% 0.1%
EPS -0.05 0.10
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.